Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.380
+0.030 (2.22%)
Dec 20, 2024, 4:00 PM EST - Market closed
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of $8.49 million as of December 20, 2024. Its market cap has decreased by -37.14% in one year.
Market Cap
8.49M
Enterprise Value
6.56M
1-Year Change
-37.14%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since March 31, 2015, Aytu BioPharma's market cap has increased from $200.00K to $8.49M, an increase of 4,143.06%. That is a compound annual growth rate of 46.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 8.50M | -46.20% |
| Dec 29, 2023 | 15.80M | 33.90% |
| Dec 30, 2022 | 11.80M | -68.95% |
| Dec 31, 2021 | 38.00M | -50.33% |
| Dec 31, 2020 | 76.50M | 278.71% |
| Dec 31, 2019 | 20.20M | 197.06% |
| Dec 31, 2018 | 6.80M | -30.61% |
| Dec 29, 2017 | 9.80M | 9,700.00% |
| Dec 30, 2016 | 100.00K | -66.67% |
| Dec 31, 2015 | 300.00K | 50.00% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 9.08M |
| Purple Biotech | 8.92M |
| Evogene | 8.78M |
| COSCIENS Biopharma | 8.55M |
| Viracta Therapeutics | 8.51M |
| QT Imaging Holdings | 8.44M |
| BioCardia | 8.44M |
| RedHill Biopharma | 8.29M |